An Open Pilot Study of the Combination of Escitalopram and Bupropion-SR for Outpatients With Major Depressive Disorder

OBJECTIVE: Monotherapy with a selective serotonin reuptake inhibitor (SSRI) is the most common initial treatment for major depressive disorder (MDD), but this monotherapy leads to remission in fewer than a third of patients. The combination of the SSRI escitalopram and bupropion-SR is commonly used...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Leuchter, Andrew F., Lesser, Ira M., Trivedi, Madhukar H., Rush, A. John, Morris, David W., Warden, Diane, Fava, Maurizio, Wisniewski, Stephen R., Luther, James F., Gaynes, Bradley N., Stewart, Jonathan W.
Format: Artigo
Idioma:Inglês
Publicat: 2008
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2778329/
https://ncbi.nlm.nih.gov/pubmed/18832958
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/01.pra.0000336754.19566.65
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars